{
    "nct_id": "NCT03730051",
    "official_title": "Contrast Enhanced Breast MRI: Comparison of Two Macrocyclic Gadolinium-Based Contrast Agents: Gadoterate Meglumine (Dotarem) and Gadobutrol (Gadavist). A Prospective Study.",
    "inclusion_criteria": "* Females age 18 and older\n* Scheduled to undergo a clinically indicated MRI of the breast with contrast.\n* Have undergone, are scheduled to undergo, or are likely to be scheduled to undergo a breast tissue sampling exam with histology results available within 6 months of their MRI.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Pregnant\n* Have already begun therapeutic treatment for breast cancer including surgery (lumpectomy or mastectomy), radiotherapy, or chemotherapy.\n* Pre Menopause women outside of the 7-14 days from cycle",
    "miscellaneous_criteria": ""
}